【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Introduction 12
2.1 Drug Delivery Infusion Systems Overview 12
3 Products under Development 14
3.1 Drug Delivery Infusion Systems – Pipeline Products by Stage of Development 14
3.2 Drug Delivery Infusion Systems – Pipeline Products by Segment 15
3.3 Drug Delivery Infusion Systems – Pipeline Products by Territory 16
3.4 Drug Delivery Infusion Systems – Pipeline Products by Regulatory Path 17
3.5 Drug Delivery Infusion Systems – Pipeline Products by Estimated Approval Date 18
3.6 Drug Delivery Infusion Systems – Ongoing Clinical Trials 19
4 Drug Delivery Infusion Systems – Pipeline Products under Development by Companies 20
4.1 Drug Delivery Infusion Systems – Pipeline Products by Stage of Development 20
4.2 Drug Delivery Infusion Systems – Pipeline Products by Stage of Development 22
5 Drug Delivery Infusion Systems Companies and Product Overview 24
5.1 410 Medical Innovation, LLC Company Overview 24
5.1.1 410 Medical Innovation, LLC Pipeline Products & Ongoing Clinical Trials Overview 24
5.2 Acuros GmbH Company Overview 25
5.2.1 Acuros GmbH Pipeline Products & Ongoing Clinical Trials Overview 25
5.3 AktiVax Inc. Company Overview 26
5.3.1 AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.4 Alnylam Pharmaceuticals, Inc. Company Overview 27
5.4.1 Alnylam Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.5 Anesthesia Safety Products, LLC Company Overview 29
5.5.1 Anesthesia Safety Products, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
5.6 AngioDynamics, Inc. Company Overview 30
5.6.1 AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.7 Automedics Medical Systems Company Overview 34
5.7.1 Automedics Medical Systems Pipeline Products & Ongoing Clinical Trials Overview 34
5.8 Baxter International Inc. Company Overview 35
5.8.1 Baxter International Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.9 BioCardia, Inc. Company Overview 36
5.9.1 BioCardia, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.10 Debiotech S.A. Company Overview 38
5.10.1 Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 38
5.11 Delpor, Inc. Company Overview 40
5.11.1 Delpor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.12 Edwards Lifesciences Corporation Company Overview 42
5.12.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 42
5.13 Eksigent Technologies, LLC Company Overview 43
5.13.1 Eksigent Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 43
5.14 Eli Lilly and Company Company Overview 45
5.14.1 Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview 45
5.15 Flowonix Medical, Inc. Company Overview 47
5.15.1 Flowonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.16 FluidSynchrony, LLC Company Overview 48
5.16.1 FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.17 Fluonic, Inc. Company Overview 49
5.17.1 Fluonic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.18 Fresenius Kidney Care Company Overview 50
5.18.1 Fresenius Kidney Care Pipeline Products & Ongoing Clinical Trials Overview 50
5.19 Imagnus Biomedical Inc. Company Overview 51
5.19.1 Imagnus Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.20 Innovfusion Pte. Ltd. Company Overview 52
5.20.1 Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 52
5.21 Intarcia Therapeutics, Inc. Company Overview 55
5.21.1 Intarcia Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.22 IRadimed Corporation Company Overview 59
5.22.1 IRadimed Corporation Pipeline Products & Ongoing Clinical Trials Overview 59
5.23 Ivenix, Inc. Company Overview 61
5.23.1 Ivenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
5.24 LifeMedix, LLC Company Overview 63
5.24.1 LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 63
5.25 Lynntech, Inc. Company Overview 64
5.25.1 Lynntech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.26 Medallion Therapeutics, Inc. Company Overview 65
5.26.1 Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
5.27 Medical Device Creations Ltd. Company Overview 66
5.27.1 Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview 66
5.28 MedPrime Technologies Pvt. Ltd. Company Overview 67
5.28.1 MedPrime Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
5.29 Mercator MedSystems, Inc. Company Overview 68
5.29.1 Mercator MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
5.30 Nano Precision Medical Company Overview 72
5.30.1 Nano Precision Medical Pipeline Products & Ongoing Clinical Trials Overview 72
5.31 NexGen Medical Systems, Inc. Company Overview 73
5.31.1 NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
5.32 Nipro Corporation Company Overview 74
5.32.1 Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 74
5.33 Owen Mumford Limited Company Overview 76
5.33.1 Owen Mumford Limited Pipeline Products & Ongoing Clinical Trials Overview 76
5.34 Pavmed Inc Company Overview 77
5.34.1 Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 77
5.35 PRO-IV Medical Ltd. Company Overview 78
5.35.1 PRO-IV Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78
5.36 Ratio, Inc. Company Overview 81
5.36.1 Ratio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.37 Rice University Company Overview 82
5.37.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 82
5.38 SteadyMed Therapeutics, Inc. Company Overview 83
5.38.1 SteadyMed Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
5.39 StnDrd Infusion Corporation Company Overview 85
5.39.1 StnDrd Infusion Corporation Pipeline Products & Ongoing Clinical Trials Overview 85
5.40 Tel Aviv University Company Overview 87
5.40.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 87
5.41 Terumo Corporation Company Overview 88
5.41.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 88
5.42 ToucheMedical Ltd. Company Overview 90
5.42.1 ToucheMedical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 90
5.43 Unilife Corporation Company Overview 91
5.43.1 Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 91
5.44 University of Minnesota Company Overview 93
5.44.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 93
5.45 University of Southern California Company Overview 95
5.45.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 95
6 Drug Delivery Infusion Systems – Recent Developments 96
6.1 Jun 16, 2016: Data Show Sigma Spectrum Infusion System Users Achieved 97 Percent Drug Library Compliance Rate within the First Month of Implementation 96
6.2 Jun 14, 2016: IRADIMED Announces Election of Roger Susi as Chairman of the Board 96
6.3 Jun 13, 2016: Aarti Shah named chief information officer 97
6.4 Jun 12, 2016: Intarcia Presents FREEDOM-2 Trial Results in Type 2 Diabetes Demonstrating Clinically Meaningful Superiority and Sustained Glucose Control and Weight Reduction for ITCA 650 vs. Januvia: Oral Presentation at ADA 76th Scientific Sessions 97
6.5 Jun 09, 2016: IRADIMED Provides Regulatory Update 99
6.6 Jun 07, 2016: Intarcia Announces Branding of the Medici Drug Delivery System- A Platform of Technologies Key to Advancing its Pipeline of Once-Yearly Peptide and Antibody Fragment-Based Therapeutics in Poorly Controlled Chronic Diseases 100
6.7 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 100
6.8 Jun 03, 2016: Autostart Burette Listed Through Qld Health Tender 101
6.9 Jun 01, 2016: Phillips-Medisize Acquires Medicom Innovation Partner 101
6.10 Jun 01, 2016: Flowonix Medical Raises USD10.5 Million in Venture Financing 102
6.11 Jun 01, 2016: Flowonix Medical Secures USD5 Million in Venture Debt Financing 102
6.12 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 102
6.13 May 24, 2016: Pyng Medical Reports Second Quarter Fiscal 2016 Results 104
6.14 May 24, 2016: Lilly Details Robust R&D Pipeline to Investment Community 105
6.15 May 23, 2016: Real World Data In Europe Show Majority Of Diabetic Macular Edema Patients Gain Or Maintain Vision With Iluvien At 12 Months 106
6.16 May 23, 2016: Unilife Announces Receipt of Deficiency Letter from NASDAQ 107
6.17 May 18, 2016: Study Finds 90 Percent of Pump Programming Events for High-Alert Infusion Medications are Dose Adjustments 107
6.18 May 18, 2016: Flowonix Medical Appoints Larry Heaton as CEO 108
6.19 May 18, 2016: Repro Med Systems Posts Fourth Quarter and Fiscal Year 2016 Results and Announces New Member of the Board of Directors 109
6.20 May 16, 2016: B. Braun to Showcase Its Innovative Synchronized Intelligence Infusion Platform at AACN 110
6.21 May 13, 2016: ConvaTec Healthcare May Raise USD1 Billion in IPO 110
6.22 May 13, 2016: PAVmed Announces First Quarter 2016 Financial Results 111
6.23 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 111
6.24 May 11, 2016: Steadymed Provides Corporate Update And Reports First Quarter 2016 Financial Results 111
6.25 May 10, 2016: B. Braun Medical Calls for ECRI Institute to Establish a Scientific, Protocol-Driven Methodology for Evaluating Infusion Pumps 112
6.26 May 09, 2016: Baxter Highlights Business Strategies and Innovation at 2016 Investor Conference 113
6.27 May 06, 2016: Alimera Sciences’ ILUVIEN Data Presented At 2016 ARVO 114
6.28 May 06, 2016: Intarcia Announces Successful Cardiovascular Safety Results in Phase 3 FREEDOM-CVO Trial for ITCA 650, an Investigational Therapy for Type 2 Diabetes 115
6.29 May 03, 2016: Strong start into the year – Double-digit earnings growth in constant currency – Fresenius confirms Group guidance for 2016 116
6.30 Apr 29, 2016: IRADIMED Announces First Quarter 2016 Financial Results 118
6.31 Apr 15, 2016: InfuSystem to Acquire Infusion Pump Assets from InfusAID 119
6.32 Apr 08, 2016: Fresenius Vamed lays foundation stone for new university hospital building 120
6.33 Apr 01, 2016: IRADIMED Provides Regulatory Update 120
6.34 Mar 29, 2016: Hicks Thomas Represents EMED Technologies Seeking Injunction against RMS Medical Products for Infusion Devices FDA Warns Are Adulterated and Misbranded 120
6.35 Mar 15, 2016: Zyno Medical to Feature Z-800F Set Based Anti-Free-Flow IV Pump at NHIA 121
6.36 Mar 09, 2016: Repro Med Systems Responds to FDA Warning Letter 121
6.37 Feb 26, 2016: Zyno Medical to Feature ZynoFlo Integrated Infusion System at ACCC 121
6.38 Feb 26, 2016: Zyno Medical to Feature Z-800WF IV Infusion Pump at ACCC 122
6.39 Feb 24, 2016: Alaris System Named 2015 Best In KLAS for Smart Pumps 122
6.40 Feb 24, 2016: Outstanding 2015 financial results – 25% dividend increase proposed – Positive outlook for 2016 – New mid-term growth targets 123
6.41 Feb 24, 2016: Aetna and Roxborough Memorial Hospital Agree to Three-Year Contract 127
6.42 Feb 09, 2016: Dr. Seema Kumbhat Named Fresenius Kabi USA Medical Director 128
6.43 Feb 05, 2016: IRADIMED Announces Fourth Quarter 2015 Financial Results 128
6.44 Jan 21, 2016: Mercator MedSystems Announces First Patient Enrolled in Below the Knee Clinical Trial 129
6.45 Jan 20, 2016: LifeFlow Rapid Infuser Receives Innovation Award at Pediatrics 2040 Meeting 130
6.46 Jan 13, 2016: Pfizer May Sell Infusion Pump Business of Hospira 130
6.47 Jan 11, 2016: IRADIMED Announces 2016 Annual and First Quarter Financial Guidance 131
6.48 Jan 06, 2016: Ivenix Appoints MedTech Industry Veteran Stuart A. Randle as Chief Executive Officer 131
6.49 Dec 10, 2015: IRADIMED Updates Status of 510(k) Submission 132
6.50 Dec 02, 2015: Surefire Medical Raises USD15 Million in Series C Financing 132
6.51 Nov 05, 2015: Surefire Medical Raises Additional USD4 Million in Venture Financing 132
6.52 Nov 03, 2015: IRadimed Plans to Raise up to USD40 Million in Public Offering of Shares 133
6.53 Nov 02, 2015: Flowonix Medical and Connecticut Pain Care Announce the First Implant of the Prometra II Pump in Danbury, CT 133
6.54 Oct 30, 2015: IRADIMED Announces Third Quarter 2015 Financial Results 133
6.55 Oct 30, 2015: IRADIMED Announces Dismissal of Appeal 134
6.56 Oct 28, 2015: SteadyMed Announces Positive Clinical Study Results in Support of SMT-201 for the Treatment of Post Surgical Pain in the Home Setting 134
6.57 Oct 23, 2015: Edwards Lifesciences Enters into Agreement with CareFusion 135
6.58 Oct 08, 2015: Smiths Medical Awarded Contract by Novation 135
6.59 Oct 08, 2015: Bespak Launches New Brand Identity To The Market 136
6.60 Oct 05, 2015: Medicom receives the growth award – Borsen Gazelle 2015 136
6.61 Sep 25, 2015: Surefire Medical Introduces New Precision Infusion System 136
6.62 Sep 22, 2015: B. Braun Receives FDA Clearance for Infusomat Space Pump 137
6.63 Sep 03, 2015: pSivida CEO Invited to Speak at Surfaces in BioMaterials Foundation’s BioInterface 2015 Annual Symposium 138
6.64 Sep 01, 2015: Surefire Medical Receives FDA Clearance for Precision Direct-to-Tumor Embolization Device 138
6.65 Aug 27, 2015: Hospira Announces First Installation of Plum 360 Infusion System With Hospira MedNet 138
6.66 Aug 11, 2015: Command Medical Products Announces Promotion to Vice President 139
6.67 Jul 31, 2015: Symbiq Infusion System by Hospira: FDA Safety Communication – Cybersecurity Vulnerabilities 140
6.68 Jul 30, 2015: IRADIMED Announces Second Quarter 2015 Financial Results 140
6.69 Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results 141
6.70 Jul 29, 2015: Fresenius Medical Care Reports Second Quarter 2015 Results And Confirms Guidance For Full Year 2015 142
6.71 Jul 16, 2015: Novo Nordisk Receives FDA Approval for FlexPro PenMate for People with Growth Hormone-Related Disorders 143
6.72 Jul 08, 2015: MicroPort Lifesciences Attends Diabetes and Gonadal Disorders Meeting to Promote La Fenice 144
7 Appendix 145
7.1 Methodology 145
7.2 About GlobalData 147
7.3 Contact Us 148
7.4 Disclaimer 148
【レポート販売概要】
■ タイトル：世界の薬物送達注入装置市場：医療機器パイプライン分析2016■ 英文：Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016
■ 発行日：2016年7月4日
■ 調査会社：GlobalData
■ 商品コード：GDME0209EPD
■ 調査対象地域：グローバル
- 世界の電気自動車（EV）充電器市場（2014-2018）About Charging Equipment for Electric Vehicles Electric vehicle charging equipment, also called EV charging station, electric recharging point, and charging point, is an important element in an infrastructure that supplies electric energy for the recharging of plug-in electric vehicles, including all-electric cars, neighborhood electric vehicles and plug-in hybrids. The equipment are broadly divid …
- 爆発物検知（ETD）の世界市場2019-2023About this market The rapid increase in air passenger numbers has resulted in significant changes in the standard operating procedure (SOP) of airport terminals as they need to manage this growth with minimum capacity constraints while ensuring no lapses in security protocols. Terror threats have augmented the level of security at various checkpoints, resulting in the incorporation of advanced mac …
- イベント管理ソフトウェアの世界市場The event management software market size is expected to grow from USD 5.44 Billion in 2015 to USD 9.28 Billion by 2020, at an estimated Compound Annual Growth Rate (CAGR) of 11.3% from 2015 to 2020. Continuously increasing expenditure on meeting and events across the entire industry sector is the foremost factor that is driving the need of this market. Also, the proliferated smartphone users, and …
- フマル酸の世界市場分析：用途別（食品＆飲料、ロジン紙サイズ、UPR、アルキド樹脂）、セグメント予測、-2020Global fumaric acid market is expected to reach USD 764.8 million by 2020. Increasing convenience food demand coupled with growing middle class per capita disposable income in Asia Pacific and Latin America is expected to drive the global fumaric acid market over the forecast period. Introduction of ethnic and exotic flavors by food & beverages manufacturers is also expected to prompt demand growt …
- コネクテッドカーの世界市場2016-2020The OEM segment of the global connected car market has many vendors. The aftermarket segment of the market has intense competition, which is expected to intensify during the forecast period as a result of product extensions and technological innovations. Many international players are expected to grow organically during the forecast period by expanding customer base and creating differentiated pro …
- Webアプリケーションファイアウォール（WAF）の世界市場予測（～2022年）The Web Application Firewall (WAF) market is expected to grow at a Compound Annual Growth Rate (CAGR) of 18.3% during the forecast period, due to the rise in instances of targeted attacks on web applicationsThe global WAF market size is expected to grow from USD 2.37 billion in 2017 to USD 5.48 billion by 2022, at a CAGR of 18.3%. Increasing competitiveness, in the current scenario of the business …
- Mobilizing Facebook: Analysis and Reference Guide for Mobile Social NetworkingSocial networking has become an important social communications application. Mobile Social Networking provides faster and easier communication facilities to social networks users. In addition, it opens door for developing new business models and opportunities that depend on the power of interconnections between users. In addition, mobile social networking offers creative tools and immediacy, prese …
- 世界のベンゼン及びベンゼン誘導体市場動向と予測（～2018）Benzene is a basic petrochemical which is widely used in the industry as a feedstock for manufacturing various chemicals, which are further linked to various manufacturing industries. The possibility of plummeting in the benzene derivates demand is expected to be very minimal due to a very high number of end-user markets that depend on these derivates. The fall in demand from one end-user industry …
- フライアッシュの世界市場予測（～2021）The fly ash market was valued at USD 4.54 Billion in 2016 and is projected to reach USD 5.97 Billion by 2021, at a CAGR of 5.7% between 2016 and 2021. This growth can be attributed to the growth in the construction industry, promotion of fly ash by governments of various countries, and increasing focus on the use of environment-friendly products. Among types, the Class F segment of the fly ash mar …
- グローバルにおける養鶏機械市場（～2019）The industry report Global Poultry-Keeping Machine Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for poultry-keeping machines in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, ma …
- 世界の医療用大麻市場：用途別、地域別Global Medical Marijuana Market: About this market Technavio’s medical marijuana market analysis considers sales from chronic pain, nausea, and other applications. Our study also finds the sales of medical marijuana in APAC, Europe, MEA, North America, and South America. In 2019, the chronic pain segment had a significant market share, and this trend is expected to continue over the forecast perio …
- 昆布茶の世界市場分析：風味別（オリジナル、味付）、流通経路別（スーパーマーケット、健康専門店、オンラインストア）、セグメント予測The global kombucha market is expected to reach USD 4.46 billion by 2024, according to a new report by Grand View Research, Inc. Increasing awareness of the health benefits associated with consuming probiotic drinks is projected to boost market demand over the forecast period. Kombucha helps to control liver cell toxicity and aids in detoxification, digestion, and weight loss. It also improves imm …
- Mobile Social Commerce: Social Media + Mobile Commerce Creates Market OpportunitiesThe combination of two powerful industry trends, social networking and mobile commerce, merge to become an even more powerful force that is expected to impact the industry for many years to come. While both mobile commerce and social media are in the early stages of service maturation, the two solutions are starting to come together at a time when they can both propel each other to new heights. So …
- 自動車産業におけるバイオメトリクス（生体認証）の世界市場2017-2021About Biometric Biometrics involves the authentication and identification of an individual by one or more unique biological traits such as fingerprint, facial, iris, voice, and vein recognition. Biometric technologies are considered to be more reliable when compared to authentication via numeric codes and physical devices. With advances in signal and image processing technologies, pattern recognit …
- 世界のフレーバー（風味）及びフレグランス（香料）市場2014：主要企業の戦略的分析This new 550-page report from Venture Planning Group contains 65 tables, and presents a thought-provoking analysis of the performance, capabilities, goals and strategies of the major competitors in the worldwide flavor and fragrance market. The study is designed to provide the flavor and fragrance industry executives with strategically significant competitor information, analysis, and insight …
